Ketchum John B
SEC CIK 1991806 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | Dir | 24.9K | — | — | 4 | 2023-08-29 | 2026-06-05 |
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Newcomb Jessica | Principal Accounting Off | — | $198.6K |
| 5 | Beckman Daniella | CFO | — | $126.6K |
| 6 | Ketchum John B | Dir | — | — |
| 7 | Peters Malte | Pres, CEO, Dir | — | — |
| 8 | Rothenberg Mace | Dir | — | — |
| 9 | Gall Matthew | CFO | — | — |
| 10 | Lee Sung | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 18:08 | 2026-06-05 | TNGX | Tango Therapeutics, Inc. | Ketchum John B | Dir | A - Grant | $0.00 | +4,000 | 24.9K | +19% | $0 |
| D | 2025-06-09 | 2025-06-05 | TNGX | Tango Therapeutics, Inc. | Ketchum John B | Dir | A - Grant | $0.00 | +6,250 | 20.9K | +43% | $0 |
| D | 2024-06-07 | 2024-06-05 | TNGX | Tango Therapeutics, Inc. | Ketchum John B | Dir | A - Grant | $0.00 | +4,687 | 14.7K | +47% | $0 |
| D | 2023-08-31 | 2023-08-29 | TNGX | Tango Therapeutics, Inc. | Ketchum John B | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations